Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
- VernacularTitle:Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
- Author:
Saki FUSHIMI
1
;
Yohei HORIKAWA
1
;
Hiroya MIZUTAMARI
1
;
Nobuya MIMORI
1
;
Yuhei KATO
1
;
Sayaka SATO
1
Author Information
- Keywords: proton pump inhibitors injection; potassium-competitive acid blocker; ulcer healing; gastric endoscopic submucosal dissection
- From:Journal of Rural Medicine 2020;15(3):85-91
- CountryJapan
- Language:English
- Abstract: Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome this limitation, we compared procedural outcomes and the prevention of adverse events of proton pump inhibitor injection with an orally administered active potassium-competitive acid blocker alone.Participants and Methods: We enrolled a total of 150 patients treated for superficial gastric neoplasms at a single institution between April 2015 and December 2018. Patients treated for 2 days with proton pump inhibitor injections following 12 days of oral potassium-competitive acid blocker (proton pump inhibitor group=80) were compared with patients treated for 14 days orally with potassium-competitive acid blocker alone (potassium-competitive acid blocker group=70) using propensity score analysis. We evaluated intragastric pH levels prior to endoscopic submucosal dissection, frequency of intraoperative major bleeding, procedure time, en bloc resection rate, curability, ulcer reduction rate 14 days after endoscopic submucosal dissection, and adverse events (including perforation and postoperative bleeding).Results: Propensity score analysis yielded 43 matched pairs. The comparison demonstrated similar values for the outcomes. For all cases, we observed intragastric pH levels >6.4 prior to endoscopic submucosal dissection. Postoperative bleeding rates were 2.3% (1/43) in the proton pump inhibitor group and 0.0% (0/43) in the potassium-competitive acid blocker group (P=0.315).Conclusions: Oral potassium-competitive acid blocker alone was as effective as proton pump inhibitor injection, with a low incidence of adverse events. Based on these results, proton pump inhibitor injection might be omitted during gastric endoscopic submucosal dissection.
